HEMISPHERX BIOPHARMA INC (HEB)
Institutional ownership reported to the SEC as of Q2 2019, across 3 quarters.
5
Reporting holders
$362.0K
Reported value
0.0%
Held as options
-5
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | $267.0K | 60,858 | 0.34% | new | NEW |
| BlackRock Inc. | $46.0K | 10,526 | 0.00% | new | NEW |
| A.R.T. Advisors, LLC | $44.0K | 10,022 | 0.00% | new | NEW |
| UBS Group AG | $4.0K | 847 | 0.00% | new | NEW |
| American Portfolios Advisors | $1.0K | 228 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2019 | 5 | $362.0K | 82,481 | 5 | 0 | 0 | 0.0% |
| Q1 2019 | 10 | $192.0K | 1,198,370 | 1 | 1 | 3 | 0.0% |
| Q4 2018 | 12 | $261.0K | 1,455,664 | 1 | 0 | 0 | 0.0% |